$115.07
+0.04 (+0.03%)
Performance
1D
—
1W
—
1M
—
3M
+67.25%
6M
+34.29%
1Y
+99.95%
YTD
+81.67%
Open$115.04
Previous Close$115.03
Day High$115.13
Day Low$114.99
52W High$115.13
52W Low$47.86
Volume—
Avg Volume2.28M
Market Cap6.73B
P/E Ratio—
EPS$-4.06
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$67.56
Above
SMA 200
$71.93
Above
RSI (14)
44.8
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Hold
23 analysts
Price Target
-15.7% upside
Current
$115.07
$115.07
Target
$96.95
$96.95
$73.10
$96.95 avg
$131.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 23.16M | 2.26B | 2.06B |
| Net Income | -237,880,943 | 113.46M | 99.51M |
| Profit Margin | -1,027.3% | 5.0% | 4.8% |
| EBITDA | -256,035,462 | 251.62M | 213.71M |
| Free Cash Flow | — | 62.68M | 52.56M |
| Rev Growth | — | +18.8% | +20.4% |
| Debt/Equity | — | 0.80 | 0.97 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |